UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K
CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

~~November~~January 1330, ~~2002~~2003

Date Of Report (Date of earliest event reported)

Rx Medical Services Corp.

(Exact name of registrant as specified in its charter)

1-10963

(Commission File Number)


Nevada		87-0436782

(State or other jurisdiction of incorporation)		(IRS Employer Identification No.)

888 East Las Olas Blvd., Suite 210, Fort Lauderdale, Florida 33301

(Address of principal executive offices and zip code)

(954) 462-1711

(Registrant’s telephone number including area code)

Item 1. Changes In Control Of Registrant

None

Item 2. Acquisition Or Disposition Of Assets

~~Rx Medical Services Corp. (the “Company”) is currently in~~ None ~~negotiations with an entity to take over the operation of the~~ Dickenson County Medical Center (“DCMC”). DCMC is the Company’s sole remaining operating hospital and its only current source of revenue. The Company will be forced to close DCMC immediately if these negotiations are unsuccessful.

Item 3. Bankruptcy Or Receivership

None

Item 4. Changes In Registrant’s Certifying Accountant

~~None~~ (a) On January 3, 2003, Rx Medical Services Corp. (the “Company”), was notified by Grant Thornton LLP that it had resigned as the Company’s auditors.

(b) On June 16, 2002, Grant Thornton LLP reported on the Company’s financial statements for the two fiscal years ended December 31, 2001 and 2000. These financial statements included an independent auditor’s report containing an explanatory paragraph describing the uncertainty as to the Company’s ability to continue as a going concern.

(c) In connection with the audits of the Company’s financial statements for each of the two fiscal years ended December 31, 2001 and 2000, there have been no disagreements with Grant Thornton LLP on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure, which disagreements if not resolved to the satisfaction of Grant Thornton LLP would have caused them to reference thereto in their report on the consolidated financial statements for any of the years for which an audit was undertaken.

(d) During the 2001 fiscal year and through the second quarter of the 2002 fiscal year, there have been no reportable events (as defined in Regulation S-K Item 304(a)(1)(v)).

(e) Company has requested that Grant Thornton LLP furnish it with a letter addressed to the Securities and Exchange Commission stating whether or not it agrees with the above statements. A copy of such letter dated January 30, 2003, is filed as Exhibit 16.1 to this Form 8-K.

Item 5. Other Events

~~On October 31, 2002, the Company was informed by National Century~~ None ~~Financial Enterprises, Inc. and its affiliates (“NCFE”), the~~ Company’s primary, and currently sole, financing source, that NCFE has been precluded by its financing sources from releasing funds for the purchase of receivables and therefore did not know when or whether it would be in a position to purchase any receivables in the future. The Company has not received any financing from NCFE since October 16, 2002.

Due to recent articles in various newspapers, it appears, that NCFE will no longer purchase any receivables from or fund the operational deficits of the Company. The Company’s ability to continue as a going concern is dependent on the continued funding of its operations by NCFE and without these fundings the Company’s ability to continue as a going concern has been severely impacted and more likely than not will require the Company to seek protection under Chapter 11 of the United States Bankruptcy Code while the Company seeks another financing source or an acquirer of the Company. If the Company cannot locate a new source of financing or a suitable acquisition candidate for the Company, the Company will more likely than not be required to cease operations in their entirety and file a voluntary petition under Chapter 7 of the United States Bankruptcy Code.

Due to the above mentioned the Company may not be able to comply with its financial reporting requirements and does not know at this time when, if ever, that it will file any Quarterly Reports on Form 10-Q or Annual Reports on Form 10-K.

Item 6. Resignations Of Registrant’s Directors

~~None~~ Two of the Company’s Directors, Michael J. Pickering, M.D. and Phillip E. Pearce, resigned their positions as Directors. Neither of these two individuals resigned their positions because of a disagreement with the Company on a specific matter relating to the Company’s operations, policies or practices.

Item 7. Financial Statements And Exhibits

~~None~~ Exhibit 16.1 – Letter from Grant Thornton LLP dated January 30, 2003.

Item 8. Change In Fiscal Year

None

Item 9. Regulation FD Disclosure

None

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Rx MEDICAL SERVICES CORP.
		By: /s/ Michael L. Goldberg
		Michael L. Goldberg Director, Chairman, and Chief Executive Officer
Date: November 14, 2002
Date: January 30, 2003
		By: /s/ Dennis Dolnick
		Dennis Dolnick Chief Financial Officer
Date: November 14, 2002
Date: January 30, 2003

Filing Compare · RX MEDICAL SERVICES CORP